Customer Story

Regeneron Partners With Druva and AWS for SaaS Data Protection Across Their Enterprise

Watch customer story

18,000

Microsoft 365 accounts protected 24×7 and recoverable in minutes

3,000

AWS workloads secure 24×7 with the Druva Data Resiliency Cloud

16,000

Devices around the world protected and recoverable via the Druva Cloud

About Regeneron Pharmaceuticals

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, Regeneron’s unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron’s laboratories. Regeneron’s medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases.

Regeneron is a global company headquartered in Tarrytown, New York, with operations in the U.S., Canada, Europe and Asia. They employ over 10,000 individuals and have revenue of over $16B.